C
California Neuropsychopharmacology Clinical Research Institute | CNRI Los Angeles, CA
Research site
Site insights
Top conditions
Top treatments
Lurasidone
SEP-363856
Seroquel
Quetiapine fumarate
KarXT
Lurasidone HCl
SXC-2023
ASP4345
Paliperidone Palmitate
moxifloxacin
Parent organization
This site is a part of California Neuropsychopharmacology Clinical Research Institute
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
CNRI Los Angeles
Verified by this site
Active trials
3 of 21 total trials
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
Enrolling
Major Depressive Disorder
Drug: NBI-1065845
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Enrolling
Schizophrenia
Drug: NBI-1117568
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exac...
Enrolling
Schizophrenia
Drug: placebo
Drug: iloperidone
Trial sponsors
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems